In that way, both immunophotosensitizers exhibited light-mediated cytotoxic effects on HER2/neu-hyperexpressing tumor cells (see14 and references therein) - a therapeutic strategy that could easily be transferred to selective aPDI approaches. Here, ERBB2 is linked to neoplasm.